Nurix Therapeutics Inc (NRIX) — Free Cash Flow Generation Index

Latest as of November 2023: 0.90x

Nurix Therapeutics Inc (NRIX) has a Free Cash Flow Generation Index of 0.90x as of November 2023. Free cash flow of $24.10 Million represents 1% of operating cash flow ($26.69 Million). Explore reinvestment intensity of Nurix Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.90x
Free Cash Flow / Operating CF

Free Cash Flow

$24.10 Million
USD

Operating Cash Flow

$26.69 Million
USD

Capital Expenditures

$2.58 Million
USD

Nurix Therapeutics Inc Free Cash Flow Generation Index (2019–2019)

Historical FCF Generation Index trend for Nurix Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Nurix Therapeutics Inc operating cash flow efficiency.

Annual Free Cash Flow Generation for Nurix Therapeutics Inc (2019–2019)

Year-by-year Free Cash Flow Generation Index for Nurix Therapeutics Inc. Check how aggressively does Nurix Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2019 -1.75x $-1.05 Million $601.00K $1.65 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).